sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Etelcalcetide

Medicine

Etelcalcetide

PARSABIV is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis. PARSABIV is a calcium-sensing receptor agonist

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
PARSABIV is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis. PARSABIV is a calcium-sensing receptor agonist

What it is used for

PARSABIV is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.

Side effects, and when to stop

The following adverse reactions are discussed in greater detail in other sections of the labeling:

Storing it

Storage

Store in the original carton in refrigerator at 2°C to 8°C (36°F to 46°F) to protect from light. Once removed from the refrigerator:

  • Do not expose to temperatures above 25°C (77°F).
  • Use within 7 days if stored in the original carton.
  • Use within 4 hours and do not expose to direct sunlight if removed from the original carton.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Etelcalcetide; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/etelcalcetide

APA 7th

sofidex. (2026, August 2). Etelcalcetide. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/etelcalcetide

AMA 11th

Etelcalcetide. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/etelcalcetide

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.